D-penicillamine Induced Myasthenia Gravis in Wilson’s Disease: A Case Report
DOI:
https://doi.org/10.31729/jnma.7607Keywords:
d-penicillamine; myasthenia gravis; pyridostigmine; Wilson's disease.Abstract
Myasthenia gravis is a neuromuscular junction disorder characterised by fluctuating muscle weakness, improved by using anti-cholinesterase drugs. In addition to the autoimmune aetiology, various factors such as infections, surgery, and drugs are known to precipitate the condition. We report a case of a 15-year-old boy with D-penicillamine-induced myasthenia gravis who presented with facial diplegia, dysphagia, and drooling of saliva, 6 years after the initiation of treatment for Wilson’s disease. Therefore, clinicians should be more vigilant while prescribing patients with chelating drugs like D-penicillamine with regular monitoring of the new symptoms and keeping a very low threshold for the suspicion of myasthenia gravis.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Lekhjung Thapa, Monika Thapa, Suman Bhattarai, Abhishek Man Shrestha, Nooma Sharma, Nilshan Rai, Merina Pokharel, Raju Paudel

This work is licensed under a Creative Commons Attribution 4.0 International License.
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.
